CUVITRU is a ready-to-use liquid medicine that is given under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older.
†At a minimum to be eligible, patients must have commercial insurance. Other terms and conditions apply.
1. CUVITRU. Prescribing Information, Takeda Pharmaceuticals USA Inc.; 2023.